Brexpiprazole has a low risk of dopamine D 2...

Neuropsychopharmacology Reports 2019 / 09

Brexpiprazole has a low risk of dopamine D 2 receptor sensitization and inhibits rebound phenomena related to D 2 and serotonin 5‐HT 2A receptors in rats

Amada, Naoki, Akazawa, Hitomi, Ohgi, Yuta, Maeda, Kenji, Sugino, Haruhiko, Kurahashi, Nobuyuki, Kikuchi, Tetsuro, Futamura, Takashi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Neuropsychopharmacology Reports
DOI:
10.1002/npr2.12076
Date:
September, 2019
File:
PDF, 720 KB
2019
Conversion to is in progress
Conversion to is failed